Furthermore, the expression of lipogenic genes, such as LXRα, SREBP-1c, ACC1, and FASN, is increased in the liver tissues of NAFLD patients61. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.